Although megalencephaly and hemimegalencephaly are not typical symptoms of TSC, the case reports confirm the involvement of the activation of the mTOR pathway in processes leading to brain overgrowth, similar to our studies with Tsc2+/− mice. The gene discussed is MTOR; the disease is hemimegalencephaly.